A Phase 2 Study of D-2570 in Subjects With Moderately to Severely Active Ulcerative Colitis

This study tests a new drug called D-2570 in people with moderately to severely active ulcerative colitis (UC) — a chronic inflammatory bowel disease that causes the lining of the colon to become inflamed and develop ulcers. **You may be eligible if...** - You are between 18 and 70 years old - You have been diagnosed with ulcerative colitis for at least 3 months, confirmed by endoscopy and biopsy - Your disease is moderately to severely active - You understand and agree to the study protocol **You may NOT be eligible if...** - You have had ulcerative colitis for less than 3 months - You have only mild disease activity - You have serious other health conditions that could interfere with the study drug - You have not given informed consent Talk to your doctor to see if this trial is right for you.